These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Tissue factor and inhibitor of the blood coagulation pathway in nephrotic syndrome]. Małyszko JS; Małyszko J; Myśliwiec M Pol Arch Med Wewn; 1999 Apr; 101(4):301-5. PubMed ID: 10740407 [TBL] [Abstract][Full Text] [Related]
5. The role of tissue factor pathway inhibitor in a revised coagulation cascade. Broze GJ Semin Hematol; 1992 Jul; 29(3):159-69. PubMed ID: 1641662 [No Abstract] [Full Text] [Related]
6. Extrinsic coagulation pathway inhibitor during recombinant factor VIIa infusion. Sandset PM; Abildgaard U; Hedner U; Johansson H Thromb Haemost; 1989 Dec; 62(4):1146. PubMed ID: 2617462 [No Abstract] [Full Text] [Related]
7. Tissue factor and hemostasis. Nemerson Y Blood; 1988 Jan; 71(1):1-8. PubMed ID: 3275472 [No Abstract] [Full Text] [Related]
8. Extrinsic pathway inhibitor--the key to feedback control of blood coagulation initiated by tissue thromboplastin. Sandset PM; Abildgaard U Haemostasis; 1991; 21(4):219-39. PubMed ID: 1794748 [TBL] [Abstract][Full Text] [Related]
11. The extrinsic pathway inhibitor: a regulator of tissue factor-dependent blood coagulation. Rapaport SI Thromb Haemost; 1991 Jul; 66(1):6-15. PubMed ID: 1926052 [No Abstract] [Full Text] [Related]
12. Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor.VIIa with Xa.tissue factor pathway inhibitor. Rao LV; Ruf W Biochemistry; 1995 Aug; 34(34):10867-71. PubMed ID: 7662667 [TBL] [Abstract][Full Text] [Related]
13. Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas. Welsch DJ; Novotny WF; Wun TC Thromb Res; 1991 Oct; 64(2):213-22. PubMed ID: 1811340 [TBL] [Abstract][Full Text] [Related]
15. The inhibitors of the tissue factor:factor VII pathway. Golino P Thromb Res; 2002 May; 106(3):V257-65. PubMed ID: 12356487 [TBL] [Abstract][Full Text] [Related]
16. [Modification effect of the protein component of tissue thromboplastin (factor III) on its interaction with factors VII and X]. Zubairov DM; Baĭkeev RF; Byshevskiĭ ASh; Tersenov OA Biokhimiia; 1984 Jun; 49(6):971-5. PubMed ID: 6466743 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the inhibition of tissue factor in serum. Broze GJ; Miletich JP Blood; 1987 Jan; 69(1):150-5. PubMed ID: 3024756 [TBL] [Abstract][Full Text] [Related]
18. Evidence that plasma lipoproteins inhibit the factor VIIa-tissue factor complex by a different mechanism that extrinsic pathway inhibitor. Kondo S; Kisiel W Blood; 1987 Dec; 70(6):1947-54. PubMed ID: 3315045 [TBL] [Abstract][Full Text] [Related]
19. The interaction of the protein and phospholipid components of tissue thromboplastin (factor III) with the factors VII and X. Bjorklid E; Storm E; Osterud B; Prydz H Scand J Haematol; 1975 Mar; 14(1):65-70. PubMed ID: 1121648 [TBL] [Abstract][Full Text] [Related]
20. Heparin requires both antithrombin and extrinsic pathway inhibitor for its anticoagulant effect in human blood. Abildgaard U; Lindahl AK; Sandset PM Haemostasis; 1991; 21(4):254-7. PubMed ID: 1794751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]